Search Results

You are looking at 1 - 10 of 85 items for :

  • male breast cancer x
Clear All
Open access

Piera Rizzolo, Valentina Silvestri, Virginia Valentini, Veronica Zelli, Agostino Bucalo, Ines Zanna, Simonetta Bianchi, Maria Grazia Tibiletti, Antonio Russo, Liliana Varesco, Gianluca Tedaldi, Bernardo Bonanni, Jacopo Azzollini, Siranoush Manoukian, Anna Coppa, Giuseppe Giannini, Laura Cortesi, Alessandra Viel, Marco Montagna, Paolo Peterlongo, Paolo Radice, Domenico Palli and Laura Ottini

Introduction Male breast cancer (MBC) is a rare disease, representing about 1% of all breast cancers (BCs) and less than 1% of all cancers in men ( 1 ). Germline pathogenic variants in BC genes, particularly BRCA1 , BRCA2 and PALB2 genes

Open access

V Kenan Çelik, Sercan Kapancık, Turgut Kaçan, Selen Baloglu Kaçan, Serkan Kapancık and Hasan Kılıçgün

11 adults has diabetes and this ratio will be increased 1/10 in 2040. Type II diabetes, the most common form of diabetes, increases with changing cultural and social changes. Many years ago, breast cancer was found to be more common in diabetic

Open access

Michael Ulm, Arvind V Ramesh, Keely M McNamara, Suriyan Ponnusamy, Hironobu Sasano and Ramesh Narayanan

review. Prostate and hormone receptor-positive breast cancers share the common feature of their dependence on the respective male and female hormones for their continued growth. Both estrogen receptor (ER) and androgen receptor (AR) are promoters of

Open access

T P McVeigh, R J Mulligan, U M McVeigh, P W Owens, N Miller, M Bell, F Sebag, C Guerin, D S Quill, J B Weidhaas, M J Kerin and A J Lowery

characteristics. Breast cancer ( N (%)) Thyroid cancer ( N (%)) Controls ( N (%)) Total 526* 139* (100) 724 (100) Gender  Male 3 (1) 27 (19) 53 (7)  Female 523* (99) 112* (81) 671 (93

Open access

Renea A Taylor, Jennifer Lo, Natasha Ascui and Matthew J Watt

Epidemiology of prostate cancer and obesity Prostate cancer Prostate cancer is an androgen-dependent malignancy that affects the aging male population, with the mean age at diagnosis being 66 years (1) . Over the past decade, the incidence of

Open access

Wafaa M Rashed, Anas Saad, Muneer Al-Husseini, Ahmed Mahmoud Galal, Assem Mohamed Ismael, Ahmed M Al-Tayep, Ayman El Shafie, Mahmoud Ahmed Ali and Ahmad Samir Alfaar

adrenal gland tumors as second primary cancers (clear cell adenocarcinoma, NOS (8310/3) and renal cell carcinoma (8312/3)). Both female breast (27 cases, 23.1%) and prostate (22 cases, 18.8%) were the most frequent primary cancer sites that preceded an

Open access

Zhen-yu Song, Qiuming Yao, Zhiyuan Zhuo, Zhe Ma and Gang Chen

Introduction Prostate cancer (PCa) is one of the most common malignant tumors in male. In 2017, American Cancer Society reported 161,360 cases of newly diagnosed PCa, accounting for 20% of male tumors. Furthermore, its incidence and mortality

Open access

Aida Javanbakht, Massimo D’Apuzzo, Behnam Badie and Behrouz Salehian

Clinical Neuroscience 2011 18 420 – 422 . ( ) 10.1016/j.jocn.2010.05.006 40 Fukunaga A Yazaki T Shimizu K Ochiai M . A case of pituitary metastasis in a patient with male breast cancer developing anterior

Open access

Tingting Xia, Hongru Sun, Hao Huang, Haoran Bi, Rui Pu, Lei Zhang, Yuanyuan Zhang, Ying Liu, Jing Xu, Justina Ucheojor Onwuka, Yupeng Liu, Binbin Cui and Yashuang Zhao

that this alteration might directly be a biomarker of the risk and prognosis of cancer ( 16 , 17 , 18 ). Recently, studies have focused on the role of AR in prostate ( 19 ), breast ( 20 ), hepatocellular, pancreatic and bladder cancers ( 21

Open access

Daiki Kobayashi, Nagato Kuriyama, Keita Hirano, Osamu Takahashi and Hiroshi Noto

cancer 68 18.1 Lung cancer 40 10.6 Colorectal cancer 38 10.1 Esophagus cancer 30 8 Breast cancer 21 5.6 Bladder and ureteral cancer 18 4.8 Liver cancer 14 3.7 Others 14 3